Bcl-2 Cancer Research Results

Bcl-2, B-cell CLL/lymphoma 2: Click to Expand ⟱
Source: HalifaxProj (inhibit) CGL-Driver Genes
Type: Antiapoptotic Oncogene
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL, the pro-apoptotic proteins represented by BAX and Bak, and the pro-apoptotic BH3-only proteins represented by BAD and BID.
Since the expression of Bcl-2 protein in tumor cells is much higher than that in normal cells, inhibitors targeting it have little effect on normal cells.
Scientific Papers found: Click to Expand⟱
6584- EU,    Eurycoma longifolia: an overview on the pharmacological properties for the treatment of common cancer
- Review, Var, NA
*AntiAge↑, *Inflam↓, *antiOx↑, TumCD↑, Bcl-2↓, cl‑Casp7↑, cl‑PARP↑, BAX↑, P53↑, tumCV↓, selectivity↑, *testos↑, *PSA∅,
6585- EU,    Anti-Tumor Activity of Eurycoma longifolia Root Extracts against K-562 Cell Line: In Vitro and In Vivo Study
- vitro+vivo, AML, K562
Dose↝, TumCG↓, Apoptosis↑, TumCCA↑, DNAdam↑, Akt↓, Bcl-2↓, PCNA↓,
6382- Eug,    Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells
- in-vitro, Cerv, NA
ChemoSen↑, eff↓, Bcl-2↓, COX2/PTGS2↓, IL1β↓,
6389- Eug,    Molecular Insights into the Management of Eugenol's Anticancer Action Against Colon Cancer: A Detailed Review
- Review, Colon, NA
Apoptosis↓, TumCCA↓, Inflam↓, TumMeta↓, BioAv↑, eff↓, Half-Life↓, *ROS↓, *RNS↓, *SOD↓, *Catalase↑, *GSTs↑, *MAOA↓, *neuroP↑, *DNAdam↓, Apoptosis↑, ROS↑, selectivity↑, MMP↓, Cyt‑c↓, Casp3↑, Casp9↑, TumCD↑, BAX↑, BAD↑, APAF1↑, Bcl-2↓, Bcl-xL↓, P53↑, cl‑PARP↑, TumCCA↑, cycD1/CCND1↓, CycB/CCNB1↓, CDK2↓, CDK4↓, P21↑, p27/CDKN1B↑, NF-kB↓, COX2/PTGS2↓, PGE2↓, MAPK↓, PI3K↓, Akt↓, mTOR↓, MMPs↓, EMT↓, Snail↓, Slug↓, Zeb1↓, E-cadherin↑, ChemoSen↑, CompStab↑,
6386- Eug,    A comprehensive and systematic review on potential anticancer activities of eugenol: From pre-clinical evidence to molecular mechanisms of action
- Review, Var, NA
Apoptosis↑, TumAuto↑, TumCCA↑, Inflam↝, TumCI↓, TumMeta↓, cycD1/CCND1↓, CycB/CCNB1↓, PCNA↓, NF-kB↓, Bcl-2↓, BAX↑, AIF↑, P21↑, P53↑, ChemoSen↑,
6388- Eug,    Eugenol’s anti-cancer properties, its modulation of signalling pathways, and cascades across various cancers: A review
- Review, Var, NA
Dose↝, AntiCan↑, *Inflam↓, *cardioP↑, *neuroP↑, angioG↓, TumMeta↓, *BioAv↑, *CompStab↑, *toxicity↝, antiNeop↑, TumCCA↑, Apoptosis↑, *antiOx↑, *lipid-P↓, *ROS↓, *SOD↑, *Catalase↑, *GSTs↑, *GPx↑, *iNOS↓, *COX2/PTGS2↓, *IL6↓, *TNF-α↓, *AntiArt↑, *Bacteria↓, TumAuto↑, PI3K↓, Akt↓, FOXO3↝, BAX↑, mTOR↓, NF-kB↓, P53↑, TumCG↓, CSCs↓, CD44↓, EpCAM↓, NOTCH1↓, OCT4↓, Bcl-2↓, PDK1 / PDPK1↓, HER2/EBBR2↓, BAD↓, cycD1/CCND1↓, ROS↑, Casp3↑, selectivity↑, MMP2↓, MMP9↓, TIMP1↑, VEGF↓, VEGFR1↓, RECK↑, TIMP2↑, DNAdam↑, MMP↓, Thiols↓, PARP↑, *Pain↓, E2Fs↓, survivin↓,
6336- Eug,    Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG
- in-vivo, GC, NA
Apoptosis?, Bcl-2↓, Cyt‑c↝, Casp↑, TumCI↓, angioG↓, MMPs↓, VEGF↓, VEGFR1↓, TIMP2↑, RECK↑,
6337- Eug,    Eugenol alleviated breast precancerous lesions through HER2/PI3K-AKT pathway-induced cell apoptosis and S-phase arrest
- in-vitro, BC, MCF-10AT
TumCP↓, TumCCA↑, HER2/EBBR2↓, Akt↓, PDK1 / PDPK1↓, Bcl-2↓, NF-kB↓, BAD↓, cycD1/CCND1↓,
6333- Eug,  Cisplatin,  Rad,    Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation
- in-vitro, Cerv, HeLa
TumCP↓, LDH↝, ChemoSen↑, RadioS↑, Casp3↑, BAX↑, Cyt‑c↑, Casp9↑, Bcl-2↓, COX2/PTGS2↓, IL1β↓, ROS↑, NF-kB↓, COX2/PTGS2↓, TumCCA↓, Thiols↓, GSH↓,
6330- Eug,    Molecular Mechanisms of Action of Eugenol in Cancer: Recent Trends and Advancement
- Review, Var, NA
TumCD↑, TumCCA↑, AntiCan↑, Apoptosis↑, angioG↓, TumCI↓, TumMeta↓, ChemoSen↑, ALDH↓, NF-kB↓, IL6↓, IL8↓, BAX↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, Bcl-2↓, MMP2↓, MMP9↓, EMT↓, N-cadherin↓, Snail↓, E-cadherin↑, SOX2↓, ROS↑, PCNA↓, MMP1↓, Cyt‑c↑, LDH↑, CSCs↓, OCT4↓, NOTCH1↓, EpCAM↓, CD44↓, HER2/EBBR2↓, VEGF↓, TIMP2↑, eff↑, Ca+2↑, TumVol↓, DNAdam↑, GSH↓, H2O2↑, lipid-P↑,
6846- EVO,    Evodiamine Inhibits Colorectal Cancer Growth via RTKs Mediated PI3K/AKT/p53 Signaling Pathway
- in-vitro, CRC, HT29 - in-vitro, CRC, HCT116
TumCP↓, TumCI↓, TumCCA↑, PI3K↓, AKT1↓, P53↑, Bcl-2↓, BAX↑, Apoptosis↑, p‑Casp9↑, E-cadherin↑, N-cadherin↓, MMP9↓, CSCs↓, EGFR↓, PDGFRA↓, Dose↝, TumCG↓,
6840- EVO,    Evodiamine Induces G2/M Arrest and Apoptosis via Mitochondrial and Endoplasmic Reticulum Pathways in H446 and H1688 Human Small-Cell Lung Cancer Cells
- in-vitro, Lung, H446 - in-vitro, Lung, H1688
tumCV↓, TumCCA↑, Apoptosis↑, Casp12↑, Cyt‑c↑, BAX↑, Bcl-2↓, selectivity↑, ROS↑, Ca+2↑, MMP↓,
1057- EVO,    Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion
- in-vitro, Var, NA
NF-kB↓, TNF-α↓, COX2/PTGS2↓, cycD1/CCND1↓, cMyc↓, MMP9↓, ICAM-1↓, MDR1↓, XIAP↓, Bcl-2↓, Bcl-xL↓, IAP1↓, IAP2/BIRC3↓, cFLIP↓, Bfl-1↓,
6881- FA,    Potential Therapeutic Efficacy of Ferulic Acid and Its Derivatives in the Management of Cancers: A Comprehensive Analysis With Mechanistic Insight
- Review, Var, NA
ROS↑, TumCCA↑, TumCI↓, TumCMig↓, TumCP↓, BioAv↑, BioAv↑, TP53↑, CDK2↓, CDK4↓, CDK6↓, JAK2↓, STAT6↓, tyrosinase↓, p‑Akt↓, p‑PI3K↓, mTOR↓, Ki-67↓, Casp3↑, proCasp8↑, cl‑PARP↑, BAX↑, Bcl-2↓, Mcl-1↓, MMP9↓, cycD1/CCND1↓, cycE/CCNE↓, PINK1↑, PARK2↑, MMP↓, CycD3↓, TumAuto⇅, Synergy↑, Synergy↑, ALAT↓, AST↓, ALP↓, VEGF↓, MMPs↓, angioG↓,
1654- FA,    Molecular mechanism of ferulic acid and its derivatives in tumor progression
- Review, Var, NA
AntiCan↑, Inflam↓, RadioS↑, ROS↑, Apoptosis↑, TumCCA↑, TumCMig↑, TumCI↓, angioG↓, ChemoSen↑, ChemoSideEff↓, P53↑, cycD1/CCND1↓, CDK4↓, CDK6↓, TumW↓, miR-34a↑, Bcl-2↓, Casp3↑, BAX↑, β-catenin/ZEB1↓, cMyc↓, Bax:Bcl2↑, SOD↓, GSH↓, LDH↓, ERK↑, Synergy↑, JAK2↓, STAT6↓, NF-kB↓, PYCR1↓, PI3K↓, Akt↓, mTOR↓, Ki-67↓, VEGF↓, FGFR1↓, EMT↓, CAIX/CA9↓, LC3II↑, p62↑, PKM2↓, Glycolysis↓, *BioAv↓,
1656- FA,    Ferulic Acid: A Natural Phenol That Inhibits Neoplastic Events through Modulation of Oncogenic Signaling
- Review, Var, NA
tyrosinase↓, CK2↓, TumCP↓, TumCMig↓, FGF↓, FGFR1↓, PI3K↓, Akt↓, VEGF↓, FGFR1↓, FGFR2↓, PDGF↓, ALAT↓, AST↓, TumCCA↑, CDK2↓, CDK4↓, CDK6↓, BAX↓, Bcl-2↓, MMP2↓, MMP9↓, P53↑, PARP↑, PUMA↑, NOXA↑, Casp3↑, Casp9↑, TIMP1↑, lipid-P↑, mtDam↑, EMT↓, Vim↓, E-cadherin↓, p‑STAT3↓, COX2/PTGS2↓, CDC25↓, RadioS↑, ROS↑, DNAdam↑, γH2AX↑, PTEN↑, LC3II↓, Beclin-1/ATG6↓, SOD↓, Catalase↓, GPx↓, Fas↑, *BioAv↓, cMyc↓, Beclin-1/ATG6↑, LC3‑Ⅱ/LC3‑Ⅰ↓,
1289- FA,    Cytotoxic and Apoptotic Effects of Ferulic Acid on Renal Carcinoma Cell Line (ACHN)
- in-vitro, RCC, NA
Bcl-2↓, BAX↑, Apoptosis↑,
7513- FA,    Anti-proliferative and anti-invasive effects of ferulic acid in TT medullary thyroid cancer cells interacting with URG4/URGCP
- in-vitro, Thyroid, NA
cycD1/CCND1↓, URGCP/URG4↓, CDK4↓, CDK6↓, Bcl-2↓, MMP2↓, MMP9↓, P53↑, PARP↑, PUMA↑, NOXA↑, BAX↑, Casp3↑, Casp9↑, TIMP1↑, TumCI↓, TumCMig↓, TumCCA↑, Apoptosis↑,
7507- FA,    Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3
Dose↝, ATR↑, ATM↑, P21↑, p27/CDKN1B↑, E2F4↑, RB1↑, TP53↑, cycD1/CCND1↓, CDK2↓, CDK4↓, CDK6↓, TumCP↓, Casp1↑, Casp2↑, Casp8↑, Fas↑, TRADD↑, Bcl-2↓, XIAP↓, TumCCA↑,
6858- FBZ,    Fenbendazole and Diisopropylamine Dichloroacetate Exert Synergistic Anti-cancer Effects by Inducing Apoptosis and Arresting the Cell Cycle in A549 Lung Cancer Cells
- in-vitro, Lung, A549
Synergy↑, mt-ROS↑, Apoptosis↑, Bcl-2↓, BAX↑, Casp3↑, Casp7↑, PARP↑, TumCCA↑, cycA1/CCNA1↓, cycE/CCNE↓,
6909- FIS,    Modulation of PI3K/ AKT/ mTOR and apoptosis pathway in colon cancer cells by the plant flavonoid fisetin
- in-vitro, Colon, Caco-2
AntiCan↑, tumCV↓, Bcl-2↓, PI3K↓, mTOR↓, NF-kB↓, BAX↑, *AntiDiabetic↑, *AntiCan↑, *Inflam↓, *antiOx↑, *neuroP↑,
6899- FIS,    Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3 - in-vitro, Pca, 22Rv1
Dose↝, tumCV↓, selectivity↑, TumCCA↑, cycD1/CCND1↓, cycE/CCNE↓, CDK2↑, CDK4↑, CDK6↑, P21↑, p27/CDKN1B↑, Apoptosis↑, cl‑PARP↑, Cyt‑c↑, XIAP↓, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓, PI3K↓, Akt↓,
6902- FIS,    Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells
- in-vitro, Bladder, T24/HTB-9
P53↑, NF-kB↓, TumCP↓, Apoptosis↑, TumCCA↑, P21↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK4↓, CDK2↓, BAX↑, Bak↑, Bcl-2↓, Bcl-xL↓,
2849- FIS,    Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells
- in-vitro, Melanoma, U266
TumCD↑, TumCCA↑, Casp3↑, Bcl-2↓, Mcl-1↓, BAX↑, BIM↑, BAD↑, AMPK↑, ACC↑, p‑Akt↓, p‑mTOR↓, ROS↑, eff↓,
2856- FIS,    N -acetyl- L -cysteine enhances fisetin-induced cytotoxicity via induction of ROS-independent apoptosis in human colonic cancer cells
- in-vitro, Colon, COLO205
Synergy↑, ROS↑, tumCV↓, Casp3↑, Bcl-2↓, MMP↓, eff↑,
2857- FIS,    A review on the chemotherapeutic potential of fisetin: In vitro evidences
- Review, Var, NA
COX2/PTGS2↓, PGE2↓, EGFR↓, Wnt↓, β-catenin/ZEB1↓, TCF↑, Apoptosis↑, Casp3↑, cl‑PARP↑, Bcl-2↓, Mcl-1↓, BAX↑, BIM↑, BAD↑, Akt↓, mTOR↓, ACC↑, Cyt‑c↑, Diablo↑, cl‑Casp8↑, Fas↑, DR5↑, TRAIL↑, Securin↓, CDC2↓, CDC25↓, HSP70/HSPA5↓, CDK2↓, CDK4↓, cycD1/CCND1↓, MMP2↓, uPA↓, NF-kB↓, cFos↓, cJun↓, MEK↓, p‑ERK↓, N-cadherin↓, Vim↓, Snail↓, Fibronectin↓, E-cadherin↓, NF-kB↑, ROS↑, DNAdam↑, MMP↓, CHOP/DDIT3↑, Synergy↑, ChemoSen↑,
2844- FIS,    Fisetin, a dietary flavonoid induces apoptosis via modulating the MAPK and PI3K/Akt signalling pathways in human osteosarcoma (U-2 OS) cells
- in-vitro, OS, U2OS
tumCV↓, Apoptosis↑, Casp3↑, Casp8↑, Casp9↑, BAX↑, BAD↑, Bcl-2↓, Bcl-xL↓, PI3K↓, Akt↓, ERK↓, p‑JNK↑, p‑cJun↑, p‑p38↑, ROS↑, MMP↓, mTORC1↓, PTEN↑, p‑GSK‐3β↓, GSK‐3β↑, NF-kB↓, IKKα↑, Cyt‑c↑,
2845- FIS,    Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy
- Review, Var, NA
PI3K↓, Akt↓, mTOR↓, p38↓, *antiOx↑, *neuroP↑, Casp3↑, Bcl-2↓, Mcl-1↓, BAX↑, BIM↑, BAD↑, AMPK↑, ACC↑, DNAdam↑, MMP↓, Synergy↑, ROS↑, cl‑PARP↑, Cyt‑c↑, Diablo↑, P53↑, p65↓, Myc↓, HSP70/HSPA5↓, HSP27↓, COX2/PTGS2↓, Wnt↓, EGFR↓, NF-kB↓, TumCCA↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycA1/CCNA1↓, P21↑, MMP2↓, MMP9↓, TumMeta↓, MMP1↓, MMP3↓, MMP7↓, MET↓, N-cadherin↓, Vim↓, Snail↓, Fibronectin↓, E-cadherin↑, uPA↓, ChemoSen↑, EMT↓, Twist↓, Zeb1↓, cFos↓, cJun↓, EGF↓, angioG↓, VEGF↓, eNOS↓, *NRF2↑, HO-1↑, NRF2↓, GSTs↓, ATF4↓,
2827- FIS,    The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment
- Review, Var, NA
*antiOx↑, *Inflam↓, neuroP↑, hepatoP↑, RenoP↑, cycD1/CCND1↓, TumCCA↑, MMPs↓, VEGF↓, MAPK↓, NF-kB↓, angioG↓, Beclin-1/ATG6↑, LC3s↑, ATG5↑, Bcl-2↓, BAX↑, Casp↑, TNF-α↓, Half-Life↓, MMP↓, mt-ROS↑, cl‑PARP↑, CDK2↓, CDK4↓, Cyt‑c↑, Diablo↑, DR5↑, Fas↑, PCNA↓, Ki-67↓, p‑H3↓, chemoP↑, Ca+2↑, Dose↝, CDC25↓, CDC2↓, CHK1↑, Chk2↑, ATM↑, PCK1↓, RAS↓, p‑p38↓, Rho↓, uPA↓, MMP7↓, MMP13↓, GSK‐3β↑, E-cadherin↑, survivin↓, VEGFR2/KDR/Flk1↓, IAP2/BIRC3↓, STAT3↓, JAK1↓, mTORC1↓, mTORC2↓, NRF2↑,
2828- FIS,    Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review
- Review, Var, NA
*neuroP↑, *antiOx↑, *Inflam↓, RenoP↑, COX2/PTGS2↓, Wnt↓, EGFR↓, NF-kB↓, Casp3↑, Ca+2↑, Casp8↑, TumCCA↑, CDK1↓, PI3K↓, Akt↓, mTOR↓, MAPK↓, *P53↓, *P21↓, *p16↓, mTORC1↓, mTORC2↓, P53↑, P21↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK2↓, CDK4↓, BAX↑, Bcl-2↓, PCNA↓, HER2/EBBR2↓, Cyt‑c↑, MMP↓, cl‑Casp9↑, MMP2↓, MMP9↓, cl‑PARP↑, uPA↓, DR4↑, DR5↑, ROS↓, AIF↑, CDC25↓, Dose↑, CHOP/DDIT3↑, ROS↑, cMyc↓, cardioP↑,
2839- FIS,    Dietary flavonoid fisetin for cancer prevention and treatment
- Review, Var, NA
DNAdam↑, ROS↑, Apoptosis↑, Bcl-2↓, BAX↑, cl‑Casp9↑, cl‑Casp3↑, Cyt‑c↑, lipid-P↓, TumCG↓, TumCA↓, TumCMig↓, TumCI↓, uPA↓, ERK↓, MMP9↓, NF-kB↓, cFos↓, cJun↓, AP-1↓, TumCCA↑, AR↓, mTORC1↓, mTORC2↓, TSC2↑, EGF↓, TGF-β↓, EMT↓, P-gp/ABCB1↓, PI3K↓, Akt↓, mTOR↓, Synergy↑, ROS↓, ER Stress↑, IRE1↑, ATF4↑, GRP78/BiP↑, ChemoSen↑, CDK2↓, CDK4↓, cycE/CCNE↓, cycD1/CCND1↓, P21↑, COX2/PTGS2↓, Wnt↓, EGFR↓, β-catenin/ZEB1↓, TCF-4↓, MMP7↓, RadioS↑, Synergy↑,
2832- FIS,    Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies
- Review, Var, NA
MMP↓, mtDam↑, Cyt‑c↑, Diablo↑, Casp↑, cl‑PARP↑, Bak↑, BIM↑, Bcl-xL↓, Bcl-2↓, P53↑, ROS↑, AMPK↑, Casp9↑, Casp3↑, BID↑, AIF↑, Akt↓, mTOR↓, MAPK↓, Wnt↓, β-catenin/ZEB1↓, TumCCA↑, P21↑, p27/CDKN1B↑, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, CDK6↓, TumMeta↓, uPA↓, E-cadherin↑, Vim↓, EMT↓, Twist↓, DNAdam↑, ROS↓, COX2/PTGS2↓, PGE2↓, HSF1↓, cFos↓, cJun↓, AP-1↓, Mcl-1↓, NF-kB↓, IRE1↑, ER Stress↑, ATF4↑, GRP78/BiP↑, MMP2↓, MMP9↓, TCF-4↓, MMP7↓, RadioS↑, TOP1↓, TOP2↓,
6990- Form,    Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo
- vitro+vivo, OS, U2OS
TumCP↓, Apoptosis↑, Bcl-2↓, miR-375↓, BAX↑,
6982- Form,    Formononetin: A Review of Its Anticancer Potentials and Mechanisms
- Review, Var, NA
AntiTum↑, Apoptosis↑, BAX↑, Bcl-2↓, Casp3↑, TumCCA↑, cycA1/CCNA1↓, CycB/CCNB1↓, cycD1/CCND1↓, TumCP↓, VEGF↓, FGF↓, MMP2↓, MMP9↓, Synergy↑, ChemoSen↑, chemoPv↑, p‑Akt↓, p‑STAT3↑, TumCMig↓, TumCI↓, TIMP1↑, TIMP2↑, PI3K↓, Akt↓, Dose↝, TumCG↓, TumW↓, TumVol↓, angioG↓, Casp3↑, Casp9↑, cl‑PARP↑, DNArepair↓, MMP↓, BAX↑, Bcl-2↓, DR5↑, ROS↑, eff↓, p‑ERK↓, PTEN↑, Hif1a↓, eff↑, Synergy↑, ChemoSen↑, HDAC↓, *BioAv↑, *Half-Life↝, *BioAv↝, *BioAv↑, *BioAv↑, *eff↑,
6984- Form,    Formononetin suppresses colitis-associated colon cancer by targeting lipid synthesis and mTORC2/Akt signaling
- in-vitro, Colon, HCT116 - Review, IBD, RAW264.7
*Inflam↓, AntiCan↑, *NF-kB↓, *MAPK↓, *colonLen↑, TumCG↓, Apoptosis↑, LC3II↑, Beclin-1/ATG6↑, cl‑Casp3↑, BAX↑, Bcl-2↓, IGF-1↓, ACLY↓, Acetyl-CoA↓, Fas↓, HSL/LIPE↓, ATGL/PNPLA2↓, FFA/NEFA↓, GSK‐3β↑, p‑mTOR↓, Rictor↓, p‑Akt↓, PDE3B↓, p‑PKA↓, p‑HSL/LIPE↑, TumAuto↑,
6996- Form,  MET,    Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro
- in-vitro, BC, MCF7
TumCP↓, Apoptosis↑, Bcl-2↓, p‑ERK↓, Synergy↑,
6993- Form,  ISL,    Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell
- in-vitro, CRC, HCT116
AntiTum↑, TumCG↓, Apoptosis↑, Casp↑, Bcl-2↓, Bcl-xL↓,
6977- Form,    Differential ability of formononetin to stimulate proliferation of endothelial cells and breast cancer cells via a feedback loop involving MicroRNA-375, RASD1, and ERα
- in-vitro, BC, MCF7 - in-vitro, BC, BT474 - in-vitro, BC, MDA-MB-231 - in-vitro, Nor, HUVECs
*Apoptosis↓, miR-375↝, p‑Akt↑, Bcl-2↑,
8584- FS,    Anti-Oxidant and Anti-Cancer Properties of Flaxseed
- Review, Nor, NA
*Ingr↝, *cardioP↑, *LDL↓, *lipidLev↓, *AntiDiabetic↑, *hepatoP↑, *AntiCan↑, *Analgesic↑, *AntiArt↑, *CRP↓, *TNF-α↓, *Inflam↓, *toxicity↝, *neuroP↑, *Ingr↝, *Ingr↝, *AntiViral↑, Risk↓, *Ingr↝, *hs-CRP↓, *GutMicro↑, *TJ↑, *OCLN↝, *MLC2/MYL9↝, *VCAM-1↓, *Akt2↓, *IKKα↓, *NF-kB↓, Synergy↑, HER2/EBBR2↓, MAPK↓, PI3K↓, Akt↓, EGFR↓, TumCG↓, TumMeta↓, IGF-1↓, COX2/PTGS2↓, PGE2↓, CDK4↓, TNF-α↓, IL1β↓, lipid-P↑, P53↑, MDM2↑, cl‑Casp3↑, cl‑PARP↑, cl‑Casp7↑, BAX↑, Bcl-2↓, Bax:Bcl2↑, Cyt‑c↑, Casp9↑, Ki-67↓, CYP1A1↑, p38↑, ERK↑, Synergy↑, ChemoSen↑, *BioAv↑, eff↝, Ingr↝,
8589- FS,    Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets
- Study, Var, NA
Risk↓, Ingr?, *antiOx?, *Inflam↓, *Estro↓, *Ingr↑, *neuroP↑, *Obesity↓, TumMeta↓, TumCP↓, *AntiAg↑, *AntiDiabetic↑, *ROS↓, *GutMicro↑, FOXM1↓, PCNA↓, Ki-67↓, CDK2↓, Akt↓, PDGF↓, ERK↓, p‑GSK‐3β↓, IGFR↓, p‑MDM2↓, EGFR↓, FASN↓, CYP3A4↓, COX2/PTGS2↓, Cyt‑c↑, cl‑PARP↑, Casp3↑, p‑P53↑, Bcl-2↓, VEGF↓, VEGFR2/KDR/Flk1↓, BRCA1↓, BRCA2↓, survivin↓, GADD45A↓, FAK↓, pax↓, Rho↓, Rac1↓, Cdc42↓, MMP2↓, TIMP1↑, TIMP2↑, angioG↓, MMP↓, ChemoSen↑,
1300- GA,  PacT,  carbop,    Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line
- in-vitro, BC, MCF7
TumCCA↑, Apoptosis↑, P53↑, BAX↑, Casp3↑, Bcl-2↓,
7033- GA,  OL,    Gallic Acid Enhances Olaparib-Induced Cell Death and Attenuates Olaparib Resistance in Human Osteosarcoma U2OS Cell Line
- in-vitro, OS, U2OS
tumCV↓, angioG↓, DNAdam↑, Apoptosis↑, cl‑PARP↓, Bcl-2↓, BAX↑, ROS↓, Synergy↑, TumCMig↓, VEGF↓, Casp9↑, P53↑, selectivity↑,
7031- GA,  Cisplatin,    Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway
- in-vitro, Lung, A549
TumCP↓, Apoptosis↑, BAX↑, Bcl-2↓, ChemoSen↑, JAK↓, STAT3↓,
5205- Gallo,    Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells
- in-vitro, Endo, ISH
LDH↓, TumCG↓, LDHA↓, Apoptosis↑, cl‑Casp3↑, Mcl-1↓, Bcl-2↓, TumCCA↑, ROS↑, mt-DNAdam↑, GlucoseCon↓, ATP↓, PDH↑, Pyruv↑, Glycolysis↓, TCA↑, cMyc↓, E-cadherin↑, Slug↓,
5152- GamB,    Gambogic Acid as a Candidate for Cancer Therapy: A Review
- Review, Var, NA
AntiCan↑, Apoptosis↑, TumAuto↑, TumCCA↑, TumCI↓, TumMeta↓, angioG↓, eff↑, NF-kB↓, P53↑, P21↑, MDM2↓, HSP90↓, Bcl-2↓, Cyt‑c↑, Casp↑, MMP↓, Casp3↑, Casp9↑, cl‑PARP↑, Bax:Bcl2↑, ROS↑, SIRT1↓, TrxR1↓, Fas↓, FasL↑, FADD↑, APAF1↑, DNAdam↑, NF-kB↓, STAT3↓, MAPK↓, cFos↓, EGFR↓, Akt↓, mTOR↓, AMPK↑, TumCCA↑, ChemoSen↑, P-gp/ABCB1↓, survivin↓,
5148- GamB,    Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics
- Review, Var, NA
AntiCan↑, angioG↓, ChemoSen↑, RadioS↑, VEGF↓, MMP2↓, MMP9↓, Telomerase↓, TrxR↓, ERK↓, HSP90↓, ROS↑, SIRT1↑, survivin↓, cFLIP↓, Casp3↑, Casp8↑, Casp9↑, BAD↓, BID↓, Bcl-2↓, BAX↑, STAT3↓, hTERT/TERT↓, NF-kB↓, Myc↓, Hif1a↓, FOXD3↑, BioAv↓, BioAv↑, P53↑, eff↓, OCR↓, MMP↓, PI3K↓, Akt↓, BBB↑, TumCG↓, TumMeta↓, BioAv↑,
5150- GamB,    Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway
- in-vitro, CLL, KBM-5 - in-vitro, Nor, HEK293
Apoptosis↑, ChemoSen↑, IAP1↓, IAP2/BIRC3↓, Bcl-2↓, Bcl-xL↓, TRAF1↓, cycD1/CCND1↓, cMyc↓, COX2/PTGS2↓, MMP9↓, angioG↓, VEGF↓, NF-kB↓, eff↓,
5151- GamB,    Gambogic acid affects ESCC progression through regulation of PI3K/AKT/mTOR signal pathway
- in-vitro, ESCC, KYSE-30 - in-vitro, ESCC, KYSE450
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, Bcl-2↓, BAX↑, cl‑PARP1↑, cl‑Casp3↑, cl‑Casp9↑, PI3K↓, p‑Akt↓, p‑mTOR↓, PTEN↑,
1959- GamB,    Gambogic acid induces GSDME dependent pyroptotic signaling pathway via ROS/P53/Mitochondria/Caspase-3 in ovarian cancer cells
- in-vitro, Ovarian, NA - in-vivo, NA, NA
AntiCan↑, Pyro↑, tumCV?, CellMemb↓, cl‑Casp3↑, GSDME-N↑, ROS?, p‑P53↑, eff↓, MMP↓, Bcl-2↓, BAX↑, mtDam↑, Cyt‑c↑, TumCG↓, CD4+↑, CD8+↑,
1967- GamB,    Gambogic acid induces apoptotic cell death in T98G glioma cells
- in-vitro, GBM, T98G
BAX↑, AIF↑, Cyt‑c↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, cl‑PARP↓, Bcl-2↓, ROS↑,

Showing Research Papers: 351 to 400 of 856
Prev Page 8 of 18 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 856

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 3,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 4,   antiOx↑, 9,   antiOx⇅, 2,   ARE↓, 1,   ARE↑, 1,   Catalase↓, 15,   Catalase↑, 12,   Copper↑, 1,   ENOX2↓, 1,   Fenton↑, 2,   frataxin↑, 1,   GPx↓, 4,   GPx↑, 8,   GPx1↓, 1,   GPx4↓, 8,   GPx4↑, 1,   GSH↓, 51,   GSH↑, 9,   GSH/GSSG↓, 1,   GSR↓, 1,   GSR↑, 4,   GSS↑, 1,   GSTs↓, 2,   GSTs↑, 3,   H2O2↓, 1,   H2O2↑, 7,   HO-1↓, 8,   HO-1↑, 14,   HO-1↝, 1,   Iron↑, 3,   i-Iron↑, 1,   c-Iron↑, 1,   lipid-P↓, 9,   lipid-P↑, 19,   lipid-P↝, 1,   MDA↓, 6,   MDA↑, 14,   MPO↓, 1,   NADPH/NADP+↓, 1,   NOX4↑, 1,   NQO1↓, 3,   NQO1↑, 7,   NRF2↓, 20,   NRF2↑, 21,   NRF2⇅, 1,   NRF2↝, 1,   p‑NRF2↓, 1,   PAO↑, 1,   Prx6↑, 1,   PYCR1↓, 1,   RNS↑, 2,   ROS?, 4,   ROS↓, 28,   ROS↑, 346,   ROS⇅, 9,   ROS↝, 2,   ROS∅, 1,   i-ROS↑, 4,   mt-ROS↑, 8,   SAM-e↝, 1,   SOD?, 1,   SOD↓, 18,   SOD↑, 14,   SOD1↓, 2,   SOD1↑, 2,   SOD2↓, 6,   SOD2↑, 4,   TAC?, 1,   TAC↓, 1,   TBARS↓, 1,   Thiols↓, 3,   Trx↓, 2,   Trx1↑, 1,   ox-Trx1↑, 1,   Trx2↓, 1,   TrxR↓, 6,   TrxR1↓, 7,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 1,   IronCh↑, 2,   NCOA4↑, 1,   Tf↓, 1,   Tf↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   Bfl-1↓, 1,   CDC2↓, 11,   CDC2↑, 1,   CDC25↓, 17,   compI↓, 2,   compIII↓, 2,   compV↓, 1,   EGF↓, 5,   ETC↓, 4,   HSP60/HSPD1↓, 1,   MCU↓, 1,   mitResp↓, 3,   mitResp↑, 1,   MKK7↓, 1,   mtDam↑, 27,   OCR↓, 6,   OXPHOS↓, 8,   mt-OXPHOS↓, 2,   PDH↓, 2,   PDH↑, 2,   PDH↝, 1,   PHB↓, 1,   PHB↑, 1,   PINK1↑, 3,   SIRT3↓, 3,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX?, 1,   12LOX↓, 3,   5LO↓, 3,   ACC↑, 4,   p‑ACC↑, 1,   ACC1↓, 1,   Acetyl-CoA↓, 1,   ACLY↓, 4,   ACSL4↑, 1,   ALAT↓, 2,   ALAT↑, 1,   ALAT∅, 1,   ALDOA↓, 1,   AMP↑, 1,   AMPK?, 1,   AMPK↓, 3,   AMPK↑, 26,   p‑AMPK↑, 3,   p‑AMT/GCST/T-protein↑, 1,   ATGL/PNPLA2↓, 1,   ATP↓, 23,   e-ATP↑, 1,   CAIX/CA9↓, 4,   CAIX/CA9↑, 1,   i-Cer↑, 1,   ENO1↓, 4,   FAO↑, 1,   FASN↓, 10,   FBI-1↓, 1,   FFA/NEFA↓, 1,   GALNT10↓, 1,   GAPDH↓, 3,   GLO-I↓, 1,   GLS↓, 1,   glucose↓, 3,   GlucoseCon↓, 7,   GlutaM↓, 1,   GlutMet↓, 2,   Glycolysis↓, 29,   GSK‐3β↓, 12,   GSK‐3β↑, 8,   p‑GSK‐3β↓, 6,   p‑GSK‐3β↑, 1,   H2S↑, 1,   HK1↓, 1,   HK2↓, 14,   HMG-CoA↓, 1,   HSL/LIPE↓, 1,   p‑HSL/LIPE↑, 1,   lactateProd↓, 10,   lactateProd↑, 1,   LDHA↓, 8,   LDL↓, 3,   lipidLev↓, 1,   MCT4↓, 1,   NAD↝, 1,   NADPH↓, 3,   NADPH↑, 1,   O-Glc↓, 1,   PCK1↓, 1,   PDK1 / PDPK1↓, 11,   PDKs↓, 1,   PFK↓, 2,   PFKFB4?, 1,   PFKP↓, 1,   PKM2↓, 12,   PLA2↓, 1,   Pyruv↓, 1,   Pyruv↑, 1,   p‑S6↓, 1,   SIRT1↓, 7,   SIRT1↑, 7,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   SSAT↑, 1,   TCA?, 1,   TCA↓, 3,   TCA↑, 1,   TS↓, 1,   Warburg↓, 4,  

Cell Death(tgid=5) ⓘ

AIF↑, 22,   AIF↝, 1,   APAF1↑, 15,   Apoptosis?, 4,   Apoptosis↓, 16,   Apoptosis↑, 426,   Apoptosis↝, 1,   mt-Apoptosis↑, 6,   ASC↓, 1,   ASC↑, 1,   ASK1↑, 2,   p‑ASK1↑, 1,   BAD?, 1,   BAD↓, 5,   BAD↑, 25,   p‑BAD↓, 1,   Bak↓, 1,   Bak↑, 22,   BAX↓, 11,   BAX↑, 505,   BAX⇅, 1,   BAX↝, 3,   BAX∅, 1,   Bax:Bcl2↑, 26,   Bcl-2?, 1,   Bcl-2↓, 764,   Bcl-2↑, 18,   Bcl-2↝, 3,   Bcl-2∅, 2,   cl‑Bcl-2↓, 1,   cl‑Bcl-2↑, 1,   Bcl-xL↓, 116,   Bcl-xL↑, 3,   Bcl-xL↝, 1,   Bcl-xL∅, 1,   BID↓, 2,   BID↑, 17,   BIM↓, 1,   BIM↑, 17,   BNIP3?, 2,   BNIP3↑, 5,   BOK↑, 2,   Casp↓, 1,   Casp↑, 56,   cl‑Casp↑, 2,   Casp1↓, 2,   Casp1↑, 4,   Casp10↑, 2,   Casp12?, 1,   Casp12↑, 6,   Casp12↝, 1,   cl‑Casp12↑, 2,   Casp2↑, 3,   Casp3?, 3,   Casp3↓, 6,   Casp3↑, 331,   Casp3↝, 2,   Casp3∅, 1,   cl‑Casp3↓, 1,   cl‑Casp3↑, 93,   proCasp3↓, 3,   proCasp3↑, 3,   Casp6↑, 2,   Casp7?, 1,   Casp7↑, 32,   cl‑Casp7↑, 8,   Casp8↓, 1,   Casp8↑, 67,   cl‑Casp8↑, 14,   proCasp8↑, 2,   pro‑Casp8↑, 1,   Casp9?, 1,   Casp9↓, 1,   Casp9↑, 194,   Casp9∅, 1,   p‑Casp9↑, 2,   cl‑Casp9↑, 37,   proCasp9↓, 1,   proCasp9↑, 3,   CellShr↑, 1,   cFLIP↓, 10,   Cupro↑, 1,   Cyt‑c↓, 2,   Cyt‑c↑, 180,   Cyt‑c↝, 4,   Cyt‑c?, 1,   cl‑Cyt‑c↑, 1,   Diablo↑, 8,   DIDO1/DIO-1↑, 1,   DR5↑, 34,   FADD↑, 12,   Fas↓, 2,   Fas↑, 35,   FasL↓, 1,   FasL↑, 18,   Ferroptosis↑, 9,   GranB/GZMB↝, 1,   GSDMD↑, 1,   GSDME↑, 1,   cl‑GSDME↑, 1,   GSDME-N↑, 1,   HEY1↓, 2,   IAP1↓, 21,   IAP2/BIRC3↓, 7,   IAP2/BIRC3↑, 1,   cl‑IAP2/BIRC3↑, 1,   ICAD↓, 1,   ICD↑, 2,   iNOS↓, 17,   iNOS↑, 2,   Mcl-1↓, 64,   MDM2↓, 16,   MDM2↑, 1,   p‑MDM2↓, 2,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↓, 2,   MOMP↑, 8,   NAIP↓, 2,   Necroptosis↑, 3,   necrosis↑, 4,   NOXA↑, 8,   p38↓, 7,   p38↑, 32,   p‑p38↓, 7,   p‑p38↑, 13,   Paraptosis↑, 2,   Perforin↝, 1,   pS2/TFF1↓, 1,   PUMA↑, 10,   Pyro↑, 7,   RIP3↑, 2,   p‑RIP3↑, 1,   survivin↓, 118,   survivin↑, 1,   survivin↝, 1,   TNFR 1↑, 4,   TRAIL↑, 9,   TRAILR↑, 2,   TumCD↓, 2,   TumCD↑, 29,   TUNEL↑, 1,   XIAP?, 1,   XIAP↓, 56,   XIAP↑, 1,   YAP/TEAD↓, 4,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 182,   Akt↑, 6,   Akt↝, 1,   p‑Akt↓, 70,   p‑Akt↑, 1,   AKT1↓, 6,   Akt2↓, 1,   AMPKα↑, 1,   BRAF↝, 1,   CaMKII ↓, 2,   Cavin3↓, 1,   CIP2A↓, 1,   CK2↓, 4,   cMET↓, 2,   p‑cMET↑, 2,   cSrc↓, 4,   EGFR↓, 31,   EGFR↑, 2,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 60,   ERK↑, 17,   p‑ERK↓, 27,   p‑ERK↑, 6,   FGFR1↓, 4,   FGFR2↓, 1,   FOXD3↑, 1,   HCAR2↑, 1,   HER2/EBBR2↓, 15,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 3,   Hippo↓, 1,   HRAS↓, 1,   IGF-1R↓, 3,   IGFR↓, 1,   IKKα↓, 10,   IKKα↑, 1,   p‑IKKα↓, 1,   IκB↓, 1,   IκB↑, 2,   p‑IκB↓, 2,   JAK↓, 5,   JAK1↓, 8,   JAK1↑, 1,   JAK2↓, 23,   p‑JAK2↓, 2,   JNK↓, 5,   JNK↑, 33,   JNK↝, 1,   p‑JNK↓, 2,   p‑JNK↑, 10,   cl‑JNK↑, 1,   LATS1↓, 1,   LIFR/CD118↓, 1,   LIMK1↓, 1,   MAP2K1/MEK1↓, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK?, 1,   MAPK↓, 40,   MAPK↑, 20,   MAPK↝, 1,   p‑MAPK↓, 3,   p‑MAPK↑, 4,   MARK4↓, 2,   MEK↓, 6,   p‑MEK↓, 2,   p‑MEK↑, 1,   MKK4↓, 1,   Mst1↑, 1,   mTOR↓, 91,   mTOR↑, 3,   mTOR↝, 1,   p‑mTOR↓, 22,   mTORC2↓, 4,   p‑p42↓, 1,   p70S6↓, 1,   p70S6↑, 1,   P70S6K↓, 6,   p‑P70S6K↓, 2,   p‑P90RSK↑, 1,   PDE3B↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 3,   PI3K↓, 130,   PI3K↑, 1,   PI3K↝, 1,   p‑PI3K↓, 16,   p‑PI3K↑, 1,   PI3K/Akt↓, 9,   PI3K/Akt↑, 1,   PI3K/Akt↝, 1,   PI3k/Akt/mTOR↓, 1,   PI3k/Akt/mTOR↝, 1,   PIAS-3↑, 2,   PIK3CA↓, 1,   PKA↓, 1,   p‑PKA↓, 1,   PKCδ↓, 8,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↓, 3,   PTEN↑, 33,   PTEN↝, 2,   PTPN6↑, 1,   Raf↓, 8,   e-Raf↓, 1,   c-Raf↓, 1,   RAS↓, 10,   RAS↑, 1,   Rictor↓, 1,   RIP1↓, 1,   RIP1↑, 1,   RTK-RAS↓, 1,   p‑S6K↓, 2,   SHP1↓, 1,   SHP1↑, 3,   Sp1/3/4↓, 13,   Src↓, 5,   p‑Src↓, 1,   c-Src↓, 1,   STAT↓, 6,   STAT3↓, 88,   STAT3↑, 4,   p‑STAT3↓, 22,   p‑STAT3↑, 1,   STAT4↑, 1,   STAT5↓, 2,   STAT6↓, 2,   p‑STAT6↓, 1,   STK11/LKB1↑, 1,   p‑STK11/LKB1↑, 1,   THEM4/CTMP↑, 1,   TSC2↑, 4,   p‑TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

Ac-histone H3↑, 1,   AntiThr↑, 1,   ATF3↑, 3,   ATF4↓, 1,   ATF4↑, 16,   ATFs↑, 1,   CBP↓, 1,   ChrMod↑, 1,   cJun↓, 7,   cJun↑, 5,   p‑cJun↑, 1,   cMyc↓, 56,   cMyc↑, 2,   DNMT1↓, 8,   DNMT3A↓, 3,   DNMTs↓, 7,   EZH2↓, 5,   FOXM1↓, 7,   FOXO↑, 2,   FOXO1↓, 1,   FOXO1↑, 4,   FOXO3↓, 1,   FOXO3↑, 4,   FOXO3↝, 1,   p‑FOXO3↓, 1,   FOXO4↓, 1,   FOXO4↑, 1,   H3↓, 3,   H3↑, 1,   p‑H3↓, 1,   ac‑H3↑, 1,   H3K27ac↓, 1,   H4↓, 1,   ac‑H4↑, 1,   ac‑H4∅, 1,   HATs↓, 4,   HATs↑, 1,   HDAC↓, 26,   HDAC1↓, 9,   HDAC10↑, 1,   HDAC2↓, 6,   HDAC3↓, 6,   HDAC4↓, 1,   HDAC6↓, 2,   HES1↓, 1,   HOXB-AS1↓, 1,   IRF1↑, 1,   KCNQ1OT1↓, 1,   miR-106b↓, 2,   miR-107↑, 1,   miR-122-5p↑, 1,   miR-125b↓, 1,   miR-133a-3p↑, 1,   miR-134↑, 1,   miR-139-5p↑, 2,   miR-155↓, 3,   miR-17↓, 1,   miR-195↑, 1,   miR-21↓, 7,   miR-21↑, 1,   miR-221↓, 1,   miR-224↓, 1,   miR-25-5p↑, 1,   miR-27a-3p↓, 3,   miR-27a-3p↑, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   miR-340↓, 1,   miR-34a↓, 2,   miR-34a↑, 10,   miR-375↓, 1,   miR-375↝, 1,   miR-384↑, 1,   miR-409-3p↑, 1,   miR-422a↑, 1,   miR-497↑, 1,   miR-548ah-5p↑, 1,   miR-590-3p↑, 1,   Myc↓, 7,   n-MYC↓, 2,   NR1D2↓, 1,   OCT4↓, 15,   OCT4↑, 1,   other?, 1,   other↓, 4,   other↑, 4,   other↝, 9,   PhotoS↑, 3,   Set9↑, 1,   sonoS↑, 2,   SOX2↓, 9,   SOX4↑, 1,   SOX9?, 1,   SUV39H↓, 1,   TCF-4↓, 2,   TET3↑, 1,   TFE3↑, 1,   tumCV?, 3,   tumCV↓, 112,   tumCV∅, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 2,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 36,   CRT↑, 1,   CUL1↝, 1,   CUL5↝, 1,   EDEM↑, 1,   eIF2α↓, 2,   eIF2α↑, 10,   p‑eIF2α↓, 1,   p‑eIF2α↑, 6,   ER Stress↓, 1,   ER Stress↑, 48,   GRP78/BiP?, 1,   GRP78/BiP↓, 3,   GRP78/BiP↑, 13,   GRP94↑, 1,   HSF1↓, 1,   HSP27↓, 5,   HSP27↑, 2,   HSP70/HSPA5↓, 6,   HSP70/HSPA5↑, 3,   HSP90↓, 11,   HSP90↑, 3,   HSPs↓, 1,   IRE1↑, 4,   PERK↑, 10,   p‑PERK↑, 2,   SERPINH1/HSP47↓, 1,   UPR↑, 5,   XBP-1↓, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↓, 1,   ATG3↑, 3,   ATG5↑, 10,   ATG7↑, 4,   Beclin-1/ATG6↓, 3,   Beclin-1/ATG6↑, 29,   CTSB↓, 1,   CTSD↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 5,   LC3A↑, 2,   LC3B↑, 2,   LC3B-II↑, 5,   LC3I↓, 1,   LC3I↑, 1,   LC3II↓, 3,   LC3II↑, 19,   LC3s↑, 1,   MitoP↑, 1,   p62↓, 11,   p62↑, 5,   PARK2↑, 3,   RUBCN↓, 1,   SESN2↑, 1,   TumAuto?, 1,   TumAuto↑, 55,   TumAuto⇅, 1,   TumAuto↝, 1,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   ATM↑, 4,   ATR↑, 1,   BRCA1↓, 2,   BRCA1↑, 1,   BRCA2↓, 1,   DFF45↓, 3,   DFF45↑, 1,   DNA-PK↑, 1,   DNAdam↓, 2,   DNAdam↑, 76,   mt-DNAdam↑, 1,   DNArepair↓, 4,   DNArepair↑, 1,   ERCC1↓, 2,   ERCC3↑, 1,   hTERT/TERT↓, 10,   MGMT↓, 1,   p16↑, 3,   P53↓, 9,   P53↑, 177,   P53↝, 1,   p‑P53↓, 2,   p‑P53↑, 10,   ac‑P53↑, 1,   p53 Wildtype↓, 1,   PARP↓, 10,   PARP↑, 35,   PARP↝, 1,   p‑PARP↑, 2,   cl‑PARP↓, 3,   cl‑PARP↑, 134,   cl‑PARP∅, 1,   PARP1↓, 2,   PARP1↑, 2,   cl‑PARP1↑, 5,   PCNA↓, 51,   PCNA↑, 1,   POLD1↓, 1,   RAD51↓, 1,   RAD51↑, 1,   SIRT6↓, 1,   Telomerase↓, 11,   TOP1↓, 4,   TOP1↝, 1,   TOP2↓, 5,   TP53↑, 3,   TRF2↓, 1,   UHRF1↓, 1,   XRCC1↓, 1,   γH2AX↓, 1,   γH2AX↑, 12,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 29,   CDK1↑, 1,   CDK1/2/5/9↓, 1,   CDK2↓, 44,   CDK2↑, 5,   CDK4↓, 51,   CDK4↑, 2,   CDK4/6↓, 3,   CDK6↓, 21,   CDK6↑, 1,   CHK1↓, 4,   CHK1↑, 1,   p‑CHK1↑, 1,   Chk2↓, 3,   Chk2↑, 1,   ChrCon↑, 3,   Cyc↓, 5,   Cyc↝, 1,   cycA1/CCNA1↓, 14,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 43,   CycB/CCNB1↑, 5,   cycD1/CCND1↓, 143,   cycD1/CCND1↑, 3,   cycD1/CCND1↝, 2,   CycD3↓, 5,   cycE/CCNE↓, 24,   cycE/CCNE↑, 2,   cycE1↓, 3,   cycF↓, 1,   E2F4↑, 1,   E2Fs↓, 3,   FBXO5/EMI1↓, 1,   GADD45A↓, 1,   GADD45A↑, 2,   Ki-67↓, 44,   MAD↓, 1,   mitA↓, 1,   p19↑, 1,   P21?, 1,   P21↓, 8,   P21↑, 92,   P21↝, 2,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 40,   PLK1↓, 1,   pRB↓, 2,   pRB↑, 1,   p‑pRB↓, 3,   RB1↓, 2,   RB1↑, 3,   p‑RB1↓, 2,   cl‑RB1↓, 1,   Securin↓, 1,   TubPol↓, 1,   TumCCA↓, 8,   TumCCA↑, 289,   WEE1↑, 3,   β-Tubulin↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 2,   p‑4E-BP1↓, 2,   ALDH↓, 3,   ALDH1A1↓, 3,   BMI1↓, 1,   BMP7/OP1↓, 2,   BMPs↑, 1,   CD133↓, 9,   CD133↑, 1,   CD24↓, 1,   CD34↓, 1,   CEBPA↑, 1,   cFos↓, 8,   cFos↑, 1,   cMYB↓, 1,   CSCs↓, 37,   Diff↓, 2,   Diff↑, 2,   EIF4E↓, 1,   EP4/PTGER4↑, 1,   FGF↓, 4,   Gli↓, 2,   Gli1↓, 20,   HH↓, 17,   HMGCR↓, 1,   IGF-1↓, 9,   IGF-2↓, 1,   IGFBP3↑, 5,   JAG1↓, 1,   Jun↓, 1,   Ki-67↓, 44,   Let-7↑, 2,   MCM2↓, 1,   mTORC1↓, 7,   p‑mTORC1↓, 1,   Nanog↓, 14,   Nanog↑, 1,   Nestin↓, 3,   NOTCH↓, 13,   NOTCH↑, 1,   NOTCH⇅, 1,   NOTCH1↓, 15,   NOTCH2↓, 1,   NOTCH3↓, 3,   OGFr↑, 2,   p300↓, 1,   PCLAF↓, 1,   PTCH1↓, 9,   PTCH2↓, 1,   SAL↑, 1,   Shh↓, 13,   Smo↓, 9,   p‑STAT1↓, 1,   Sufu↑, 1,   TumCG?, 3,   TumCG↓, 147,   TumCG↑, 4,   TumCP?, 1,   TumCP↓, 229,   TumCP↑, 4,   tyrosinase↓, 2,   URGCP/URG4↓, 1,   Wnt?, 1,   Wnt↓, 34,   Wnt/(β-catenin)↓, 3,  

Migration(tgid=13) ⓘ

AntiAg?, 1,   AntiAg↑, 3,   AP-1↓, 9,   AP-1↑, 1,   AP-1↝, 2,   ATPase↓, 2,   AXL↓, 4,   Ca+2↓, 4,   Ca+2↑, 40,   Ca+2↝, 3,   i-Ca+2↑, 1,   mt-Ca+2↑, 1,   CAFs/TAFs↓, 2,   cal2↑, 4,   CCN2/CTGF↓, 2,   Cdc42↓, 2,   COL1↓, 2,   COL3A1↓, 1,   CTNNB1↓, 1,   DLC1↑, 3,   E-cadherin↓, 8,   E-cadherin↑, 57,   EMT↓, 72,   EMT↑, 1,   EpCAM↓, 3,   F-actin↓, 1,   FAK↓, 18,   p‑FAK↓, 3,   Fibronectin↓, 6,   GIT1↓, 1,   GLI2↓, 9,   hnRNPA1↓, 1,   IQGAP3↓, 1,   ITGA5↓, 1,   ITGB1↓, 3,   ITGB3↓, 1,   ITGB4↓, 1,   LAMs↓, 2,   LEF1↓, 3,   LRP1↓, 1,   MALAT1↓, 1,   MET↓, 4,   MET↑, 2,   p‑MET↓, 1,   MMP-10↓, 1,   MMP1↓, 4,   MMP13↓, 5,   MMP16↓, 1,   MMP2↓, 99,   MMP2↝, 1,   MMP3↓, 9,   MMP7↓, 10,   MMP9↓, 117,   MMPs↓, 32,   MRGPRF↓, 1,   MTA1↓, 2,   MUC4↓, 3,   N-cadherin↓, 37,   NFAT↑, 1,   p44↓, 1,   p‑p44↓, 2,   PAI-1/SERPINE1↑, 1,   PAK1↓, 1,   PAK1↑, 1,   pax↓, 1,   p‑pax↓, 1,   PDGF↓, 4,   Rac1↓, 4,   RECK↑, 2,   Rho↓, 5,   ROCK1↓, 3,   Sharpin↓, 1,   Slug↓, 19,   SMAD2↓, 2,   p‑SMAD2↓, 2,   SMAD3↓, 1,   SMAD3↑, 1,   p‑SMAD3↓, 2,   SMAD4↑, 1,   Snail?, 1,   Snail↓, 31,   TET1↑, 2,   TGF-β↓, 16,   TGF-β↑, 3,   TIMP1↓, 3,   TIMP1↑, 10,   TIMP2↓, 2,   TIMP2↑, 13,   TIMP3↑, 1,   TRIB3↑, 1,   TSC1↑, 1,   TSP-1↑, 2,   TumCA↓, 3,   TumCA↑, 1,   TumCI?, 2,   TumCI↓, 102,   TumCI↑, 1,   TumCMig?, 1,   TumCMig↓, 105,   TumCMig↑, 1,   TumMeta↓, 68,   TumMeta↑, 5,   TumPF↓, 1,   Twist↓, 21,   TXNIP↑, 1,   Tyro3↓, 2,   uPA↓, 21,   uPAR↓, 2,   Vim?, 1,   Vim↓, 41,   Vim↑, 1,   Zeb1↓, 15,   ZEB2↓, 3,   α-SMA↓, 1,   α-tubulin↓, 1,   α-tubulin↑, 1,   β-catenin/ZEB1↓, 47,   β-catenin/ZEB1↑, 2,   β-catenin/ZEB1↝, 1,   cl‑β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 83,   angioG↑, 2,   CCN1/CYR61↓, 1,   CD31/PECAM-1↓, 9,   Endoglin↑, 1,   eNOS↓, 1,   HIF-1↓, 3,   Hif1a↓, 57,   LOX1↓, 2,   NO↓, 4,   NO↑, 5,   VCAM-1↓, 5,   VEGF↓, 125,   VEGF↑, 1,   VEGF↝, 1,   VEGFR1↓, 3,   VEGFR2/KDR/Flk1↓, 17,   p‑VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 2,   BBB∅, 1,   CellMemb↓, 1,   CLDN1↓, 1,   CX43/GJA1↓, 1,   EPR↑, 3,   GLUT1↓, 12,   GLUT1↑, 1,   GLUT3↓, 2,   GLUT3↑, 1,   GLUT4↓, 2,   KCNH2/hERG↓, 1,   MMP↓, 198,   MMP↑, 1,   MPT↑, 5,   NHE1↓, 1,   SLC12A5↝, 1,   TRPM7↓, 1,   TRPV1↑, 2,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ANXA1↓, 1,   CB2 / CNR2↑, 3,   CCR7↓, 2,   CD25+↑, 1,   CD4+↓, 1,   CD4+↑, 4,   CD44↓, 12,   CD8+↑, 4,   cDC2↓, 5,   COX2/PTGS2↓, 80,   COX2/PTGS2↑, 2,   COX2/PTGS2↝, 2,   CXCL1↓, 1,   CXCL12↓, 2,   CXCR2↓, 2,   CXCR4↓, 17,   CXCR4↑, 1,   DR4↑, 12,   FOXP3↓, 2,   FOXP3↑, 1,   HCAR2↑, 1,   HLA↑, 1,   HLA-I/II↑, 1,   HMGB1↓, 1,   HMGB1↑, 1,   ICAM-1↓, 13,   IFN-γ↓, 4,   IFN-γ↑, 5,   IL1↓, 7,   IL1↑, 1,   IL10↓, 4,   IL10↑, 1,   IL12↓, 2,   IL12↑, 2,   IL1α↓, 1,   IL1β↓, 16,   IL1β↑, 3,   IL2↓, 2,   IL2↑, 7,   IL33↑, 1,   IL4↓, 1,   IL4↑, 1,   IL5↓, 1,   IL6↓, 50,   IL6↑, 2,   IL6↝, 1,   IL7↓, 1,   IL8↓, 13,   Imm↑, 12,   Imm↝, 1,   Inflam↓, 38,   Inflam↝, 1,   LTA/TNF-β↓, 1,   pol-M1↑, 1,   M2 MC↓, 2,   MCP1/CCL2↓, 4,   MCT1↓, 1,   MDSCs↓, 1,   mPGES-1↓, 1,   NAF1↓, 1,   NF-kB?, 1,   NF-kB↓, 175,   NF-kB↑, 11,   NF-kB↝, 1,   p‑NF-kB↓, 3,   p‑NF-kB↑, 1,   NK cell↑, 3,   NLRP3↓, 2,   NLRP3↑, 2,   p65↓, 10,   p‑p65↓, 5,   ac‑p65↓, 1,   ac‑p65↑, 2,   PD-1↓, 3,   PD-L1↓, 8,   PD-L1↑, 1,   PGE1↓, 1,   PGE2↓, 13,   PSA↓, 9,   PSA↝, 1,   RAGE↓, 2,   RANTES↓, 1,   SOCS-3↑, 1,   SOCS1↑, 2,   T-Cell↑, 3,   TCF↓, 2,   TCF↑, 1,   TCF↝, 1,   Th1 response↑, 3,   Th17↑, 1,   TLR4↓, 6,   TLR4↝, 1,   TNF-α↓, 42,   TNF-α↑, 11,   TNF-α↝, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,   TRADD↑, 2,   TRAF1↓, 1,   Treg lymp↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

PTN↓, 1,  

Protein Aggregation(tgid=19) ⓘ

APOE4↑, 1,   BACE/β-secretase↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   AhR↓, 1,   AhR↑, 1,   AR↓, 16,   AR↝, 1,   ER-α36↓, 2,   ERα/ESR1↓, 2,   ERβ/ESR2↑, 1,   GR↝, 1,   PPARα↓, 1,   PPARγ↓, 5,   PPARγ↑, 9,   RANKL↓, 1,   SRC3↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 3,   AKR1B10↓, 1,   BioAv↓, 30,   BioAv↑, 33,   BioAv↝, 8,   BioEnh↑, 1,   ChemoSen?, 1,   ChemoSen↓, 1,   ChemoSen↑, 144,   ChemoSen↝, 1,   CompStab↑, 3,   CompStab↝, 2,   CYP1A1↓, 2,   CYP1A1↑, 2,   CYP1B1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 4,   Dose↓, 3,   Dose↑, 8,   Dose↝, 65,   Dose∅, 8,   eff↓, 88,   eff↑, 89,   eff↝, 8,   GSTA1↑, 1,   GSTM1↑, 1,   GSTP1/GSTπ↓, 1,   Half-Life↓, 7,   Half-Life↝, 8,   Half-Life∅, 1,   MDR1↓, 6,   MDR1↑, 1,   MRP↓, 1,   MRP1/ABCC1↓, 3,   P-gp/ABCB1↓, 18,   P450↓, 2,   RadioS↑, 43,   selectivity↓, 1,   selectivity↑, 108,   Synergy?, 1,   Synergy↑, 99,   TET2↓, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 3,   ALAT↓, 2,   ALAT↑, 1,   ALAT∅, 1,   ALP↓, 2,   AR↓, 16,   AR↝, 1,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   AST∅, 1,   BRAF↝, 1,   BRCA1↓, 2,   BRCA1↑, 1,   CA19-9↓, 1,   CEA↓, 3,   CRP↓, 4,   E6↓, 3,   E7↓, 3,   EGFR↓, 31,   EGFR↑, 2,   EGFR↝, 1,   p‑EGFR↓, 1,   ERα/ESR1↓, 2,   EZH2↓, 5,   FOXM1↓, 7,   HER2/EBBR2↓, 15,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 10,   IL6↓, 50,   IL6↑, 2,   IL6↝, 1,   LDH?, 1,   LDH↓, 13,   LDH↑, 6,   LDH↝, 2,   i-LDH↓, 1,   Maspin↑, 1,   Myc↓, 7,   NSE↓, 1,   PD-L1↓, 8,   PD-L1↑, 1,   PSA↓, 9,   PSA↝, 1,   PSADT↑, 1,   RAGE↓, 2,   TG/TAG↓, 1,   TP53↑, 3,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan?, 1,   AntiCan↓, 3,   AntiCan↑, 61,   AntiCan?, 1,   AntiCan∅, 1,   antiCG↓, 1,   antiD↑, 1,   antiNeop↑, 4,   AntiTum↓, 2,   AntiTum↑, 34,   cachexia↓, 2,   cardioP↑, 11,   CardioT↓, 1,   chemoP?, 1,   chemoP↑, 33,   chemoPv↑, 19,   ChemoSideEff↓, 7,   ChemoSideEff∅, 1,   hepatoP↑, 15,   K17↓, 1,   neuroP↑, 8,   NKG2D↑, 1,   Obesity↓, 1,   ORR↑, 1,   OS↑, 9,   Pain↓, 2,   PFS↓, 1,   PFS↑, 1,   Pin1↓, 2,   QoL↑, 3,   QoL∅, 1,   radioP↑, 9,   Remission↑, 1,   RenoP↑, 12,   Risk↓, 13,   Symptoms↓, 1,   toxicity?, 1,   toxicity↓, 23,   toxicity↑, 1,   toxicity↝, 12,   toxicity∅, 1,   TumNum↓, 1,   TumVol↓, 43,   TumVol↑, 2,   TumW↓, 22,   Weight↑, 2,   Weight∅, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiFungal↑, 1,   Bacteria↓, 5,   GutMicro↑, 4,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 4,   Ingr↝, 11,  
Total Targets: 1240

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 4,   antiOx↑, 90,   ARE↑, 1,   Bil↓, 1,   Catalase↓, 1,   Catalase↑, 52,   Fenton↓, 1,   GPx↓, 1,   GPx↑, 38,   GPx4↑, 2,   GSH↓, 1,   GSH↑, 49,   GSH/GSSG↑, 1,   GSR↑, 5,   GSTs↓, 1,   GSTs↑, 13,   H2O2↓, 5,   HDL↑, 2,   HO-1?, 2,   HO-1↓, 1,   HO-1↑, 26,   HO-2↓, 1,   Iron↓, 2,   Keap1↓, 5,   Keap1↑, 1,   lipid-P↓, 38,   MDA?, 1,   MDA↓, 39,   MDA↑, 1,   MPO↓, 6,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 2,   NQO1↑, 6,   Nrf1↑, 3,   NRF2?, 1,   NRF2↑, 50,   Prx↑, 1,   RNS↓, 5,   ROS?, 1,   ROS↓, 118,   ROS↑, 3,   ROS∅, 3,   SOD?, 1,   SOD↓, 2,   SOD↑, 69,   SOD1↑, 2,   SOD2↑, 4,   TAC↑, 6,   TBARS↓, 4,   Trx1↑, 1,   uricA↓, 1,   VitC↑, 1,   VitE↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↑, 1,   IronCh↑, 2,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

DRP1/DNM1L↓, 1,   FIS1↓, 1,   Insulin↑, 1,   MFN2↑, 1,   mitResp↑, 1,   mtDam↓, 5,   OCR↑, 1,   PGC-1α↓, 2,   PGC-1α↑, 2,   PINK1↑, 2,   SIRT3↑, 1,   TFAM↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↝, 1,   ACSL4↓, 1,   ALAT↓, 15,   AMPK↓, 2,   AMPK↑, 9,   p‑AMPK↑, 1,   ATP↓, 2,   ATP↑, 4,   mt-ATP↑, 1,   GAPDH↑, 1,   glucose↓, 5,   glucose↑, 1,   glucose↝, 2,   GlucoseCon↑, 1,   GSK‐3β↓, 5,   GSK‐3β↑, 1,   p‑GSK‐3β↑, 3,   H2S↑, 2,   HMG-CoA↓, 1,   LDHA↑, 1,   LDL↓, 3,   lipidLev↓, 1,   NAD↓, 1,   NAD↑, 1,   NADPH↓, 3,   NH3↓, 1,   PFK↓, 1,   PLA2↓, 1,   SIRT1↑, 7,   SREBP1/SREBF1↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   AIF↑, 1,   APAF1↓, 2,   Apoptosis↓, 31,   Apoptosis↑, 1,   ASC↓, 1,   BAX↓, 48,   BAX↑, 6,   Bax:Bcl2↓, 2,   Bcl-2↓, 12,   Bcl-2↑, 58,   Bcl-2↝, 1,   Bcl-2∅, 1,   Bcl-xL↑, 1,   Casp1↓, 3,   Casp12↓, 1,   Casp3?, 1,   Casp3↓, 35,   Casp3↑, 2,   cl‑Casp3↓, 9,   Casp8↓, 1,   Casp9↓, 10,   cl‑Casp9↓, 4,   Cyt‑c↓, 8,   Cyt‑c↑, 2,   Fas↓, 3,   FasL↓, 1,   Ferroptosis↓, 4,   GSDMD↓, 1,   iNOS↓, 20,   MLKL↓, 1,   p38↓, 2,   p‑p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 4,   Akt↑, 9,   p‑Akt↓, 1,   p‑Akt↑, 7,   Akt2↓, 1,   CaMKII ↓, 1,   CREB↑, 1,   p‑CREB↑, 4,   EGFR↓, 1,   ERK↓, 3,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   IGF-1R↓, 1,   IKKα↓, 1,   IKKα↑, 1,   IκB?, 1,   JAK↓, 2,   JAK2↑, 3,   JNK↓, 6,   JNK↑, 1,   MAPK↓, 7,   MAPK↑, 1,   Mst1↓, 2,   mTOR↓, 1,   mTOR↑, 5,   p‑mTOR↓, 1,   p‑mTOR↑, 1,   p‑p70S6↓, 1,   PDGFR-BB↓, 2,   PDGFRB↓, 1,   PI3K↓, 3,   PI3K↑, 9,   PKA↑, 1,   PKCδ↓, 1,   PKCδ↑, 1,   PP2A↑, 2,   p‑PTEN↓, 1,   RAS↓, 1,   RIP1↓, 1,   STAT3↓, 2,   STAT3↑, 6,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 5,   ATF4↓, 2,   cJun↓, 1,   p‑cJun↓, 1,   FOXO3↑, 1,   HDAC↓, 2,   HDAC2↓, 1,   HOTAIR↑, 1,   other?, 1,   other↓, 2,   other↑, 4,   other↝, 3,   SOX2↑, 1,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↓, 1,   CHOP/DDIT3↓, 5,   CHOP/DDIT3↑, 1,   ER Stress↓, 7,   GRP78/BiP↓, 6,   GRP78/BiP↑, 1,   GRP94↑, 1,   HSP70/HSPA5↑, 2,   IRE1↓, 2,   PERK↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 1,   Beclin-1/ATG6↓, 4,   Beclin-1/ATG6↑, 1,   LC3A↑, 1,   LC3II↓, 1,   LC3II↑, 2,   MitoP↑, 2,   p62↓, 3,   p62↑, 2,   PARK2↑, 3,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 6,   p16↓, 1,   P53↓, 4,   P53↑, 2,   PARP↓, 1,   cl‑PARP↓, 1,   PCNA↓, 1,   p‑γH2AX↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 1,   CycB/CCNB1↓, 1,   E2Fs↑, 1,   GADD34↓, 1,   Ki-67↑, 1,   P21↓, 2,   P21↑, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Ki-67↑, 1,   Nestin↑, 1,   neuroG↑, 2,   NOTCH1↑, 1,   TumCG↓, 1,   TumCP↓, 2,   Wnt↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 6,   AP-1↓, 2,   BACH1↓, 1,   Ca+2↓, 5,   cal2↓, 2,   Cartilage↑, 1,   E-cadherin↓, 1,   LRP1↑, 1,   MLC2/MYL9↝, 1,   MMP13↓, 2,   MMP2↓, 1,   MMP9↓, 2,   MUC1↑, 1,   PAI-1/SERPINE1↓, 1,   p‑Rac1↓, 1,   Rho↓, 1,   ROCK1↓, 1,   p‑T-cadherin↓, 1,   TGF-β↓, 2,   TregCell↑, 1,   TumCI↓, 1,   TumCMig↓, 1,   TumMeta↓, 1,   TXNIP↓, 1,   Zeb1↓, 1,   α-SMA↓, 2,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 1,   CD31/PECAM-1↓, 1,   E-sel↓, 2,   eNOS↑, 1,   Hif1a↓, 1,   NO?, 1,   NO↓, 15,   NO↑, 3,   VCAM-1↓, 3,   VEGF↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↓, 1,   BBB↑, 9,   BBB↝, 2,   BBB∅, 2,   CLDN4↑, 1,   GastroP↑, 5,   GLUT2↑, 2,   GLUT3↑, 1,   GLUT4↑, 1,   IBI↑, 2,   MMP↓, 2,   MMP↑, 12,   MMP∅, 1,   MPT↑, 1,   MUC5AC↓, 1,   OCLN↑, 2,   OCLN↝, 1,   TJ↑, 3,   TRPV1↑, 1,   ZO-1↓, 1,   ZO-1↑, 4,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   CD19↑, 1,   CD25+↑, 1,   CD4+↑, 3,   CD8+↑, 1,   COX1↓, 1,   COX2/PTGS2?, 1,   COX2/PTGS2↓, 26,   Eos↓, 1,   FOXP3↑, 1,   HMGB1↓, 4,   ICAM-1↓, 2,   IFN-γ↓, 3,   IFN-γ↑, 1,   IL1↓, 2,   IL10↓, 7,   IL10↑, 5,   IL13↑, 1,   IL17↓, 3,   IL18↓, 2,   IL1β↓, 31,   IL1β↑, 1,   IL2↓, 1,   IL22↓, 1,   IL4↓, 1,   IL4↑, 1,   IL5↓, 1,   IL6↓, 38,   IL6↑, 1,   IL8↓, 8,   Imm↓, 1,   Imm↑, 6,   Inflam↓, 108,   Inflam↑, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 2,   MIP‑1α/CCL3↓, 1,   MyD88↓, 1,   NeuroI↓, 6,   NF-kB↓, 39,   NF-kB↑, 3,   NK cell↑, 1,   NLRP3↓, 7,   PGE2↓, 9,   PGE2↑, 1,   PSA∅, 1,   RAGE↓, 4,   RANTES↓, 1,   TLR4↓, 6,   TNF-α↓, 55,   TNF-α↑, 1,   TRAF1↓, 1,   Treg lymp↝, 1,   TRIF↓, 1,   β-HEX↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   Ach↑, 4,   AChE↓, 21,   ADAM10↑, 1,   BChE↓, 5,   BDNF↓, 1,   BDNF↑, 16,   BDNF⇅, 1,   ChAT↑, 3,   MAOA↓, 2,   MAOB↓, 2,   NGF↑, 4,   PSD95↑, 3,   RELN↑, 1,   SNAP25↑, 2,   SYP↑, 1,   TrkB↑, 3,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 3,   APP↓, 3,   Aβ↓, 18,   Aβ42↓, 3,   BACE/β-secretase↓, 7,   IDE↑, 1,   PSEN1/PS1↓, 1,   tau↓, 3,   p‑tau↓, 6,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

CYP19↓, 1,   Estro↓, 1,   GR↑, 1,   PPARα↑, 1,   PPARγ↑, 3,   p‑PPARγ↓, 1,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 27,   BioAv↑, 34,   BioAv↝, 20,   BioAv∅, 1,   BioEnh↑, 1,   ChemoSen↑, 1,   CompStab↑, 1,   CYP2D6↓, 1,   Dose?, 1,   Dose↓, 1,   Dose↑, 3,   Dose↝, 13,   Dose∅, 1,   eff↓, 4,   eff↑, 9,   GSTA1↑, 1,   Half-Life↓, 2,   Half-Life↑, 1,   Half-Life↝, 14,   Half-Life∅, 1,   P-gp/ABCB1↓, 1,   P450↓, 1,   selectivity↑, 2,   Synergy↑, 10,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 15,   ALP↓, 4,   AST↓, 17,   Bil↓, 1,   BMD↑, 2,   BP↓, 4,   BUN?, 1,   BUN↓, 1,   colonLen↑, 1,   creat↓, 4,   CRP↓, 4,   EGFR↓, 1,   Ferritin↑, 1,   hs-CRP↓, 1,   IL6↓, 38,   IL6↑, 1,   LDH↓, 8,   NOS2↓, 1,   PSA∅, 1,   RAGE↓, 4,   SpO2↑, 1,   Urea↓, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 3,   AntiAge↑, 1,   antiAll↑, 12,   AntiArt↑, 8,   AntiCan↑, 18,   antiCG↑, 1,   antiD↓, 1,   AntiDiabetic↑, 20,   antiPs↑, 1,   AntiTum↓, 1,   AntiTum↑, 6,   ANXi↓, 1,   cardioP?, 2,   cardioP↑, 39,   CardioT↓, 1,   chemoP↑, 4,   chemoPv↑, 5,   cognitive↑, 22,   diuretic↑, 3,   hepatoP↓, 2,   hepatoP↑, 33,   Learn↑, 4,   memory↑, 22,   motorD↑, 5,   Mucositis↓, 2,   neuroP?, 1,   neuroP↓, 1,   neuroP↑, 70,   Obesity↓, 8,   OS↑, 1,   Pain↓, 3,   radioP↑, 5,   RenoP↓, 1,   RenoP↑, 11,   Risk↓, 2,   Sleep↑, 1,   Strength↑, 1,   Stress↓, 1,   Stroke↓, 10,   toxicity?, 1,   toxicity↓, 21,   toxicity↑, 3,   toxicity↝, 6,   toxicity∅, 9,   Weight↓, 1,   Weight↑, 1,   Wound Healing↑, 6,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 13,   AntiFungal↓, 1,   AntiFungal↑, 5,   AntiP↓, 1,   AntiP↑, 4,   AntiViral↑, 12,   Bacteria↓, 20,   Bacteria↑, 1,   Diar↓, 3,   GutMicro↑, 12,   Inf↓, 1,   Sepsis↓, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↑, 1,   Ingr↝, 6,  
Total Targets: 489

Scientific Paper Hit Count for: Bcl-2, B-cell CLL/lymphoma 2
36 Curcumin
32 Silver-NanoParticles
29 Thymoquinone
25 Quercetin
18 Luteolin
17 Apigenin (mainly Parsley)
15 Baicalein
15 EGCG (Epigallocatechin Gallate)
13 Allicin (mainly Garlic)
13 Sulforaphane (mainly Broccoli)
13 Betulinic acid
12 Fisetin
12 Shikonin
11 Berberine
11 Emodin
11 Honokiol
11 Silymarin (Milk Thistle) silibinin
10 Cisplatin
10 Melatonin
10 Resveratrol
10 Gambogic Acid
10 Garcinol
10 Licochalcone A
10 Matrine
9 Eugenol
9 Gossypol/AT-101
9 Lycopene
8 Capsaicin
8 Graviola
8 Magnolol
8 Morin
7 Magnetic Fields
7 Ashwagandha(Withaferin A)
7 D-limonene
7 Radiotherapy/Radiation
7 Beta-Caryophyllene
7 Carvacrol
7 Isoliquiritigenin
7 Juglone
7 Nimbolide
7 Piperlongumine
6 5-fluorouracil
6 Paclitaxel/Taxol
6 Phenethyl isothiocyanate
6 Boron
6 Cinnamon
6 Ursolic acid
6 Dandelion Root
6 Ferulic acid
6 Formononetin
6 Ginkgetin
6 Hibiscus sabdariffa
6 Hyperoside
6 isoorientin
6 Kaempferol
6 lambertianic acid
6 Licorice
5 Astragalus
5 Artemisinin
5 Astaxanthin
5 doxorubicin
5 Benzyl isothiocyanate
5 Boswellia (frankincense)
5 Carnosic acid
5 Cynaropicrin
5 Isobavachalcone
5 Mushroom Lion’s Mane, Hericium erinaceus
5 Rosmarinic acid
5 Urolithin
4 Cynara scolymus/Globe Artichoke/Artichoke Extract
4 Photodynamic Therapy
4 Alpha-Lipoic-Acid
4 Isovitexin
4 Metformin
4 Aloe anthraquinones
4 Biochanin A
4 Chemotherapy
4 Bufalin/Huachansu
4 α-Bisabolol / Chamomile oil
4 Crocetin
4 Ellagic acid
4 Eurycomanone
4 Geraniol
4 Ginkgolide B
4 HydroxyTyrosol
4 Indole-3-carbinol
4 Isorhamnetin
4 isoquercitrin
4 Ivermectin
4 Moringa oleifera
4 Propolis -bee glue
3 3-bromopyruvate
3 Açaí, Euterpe oleracea
3 Gemcitabine (Gemzar)
3 Allyl isothiocyanate
3 immunotherapy
3 Berbamine
3 Caffeic acid
3 Chlorogenic acid
3 chaetocin
3 chitosan
3 Chlorophyllin
3 Chrysin
3 Docetaxel
3 Evodiamine
3 Gallic acid
3 Ginkgolic acids
3 Ginger/6-Shogaol/Gingerol
3 Vitexin
3 L-Theanine
3 Laetrile B17 Amygdalin
3 Oleuropein
3 Patchouli Oil (Pogostemon cablin)
3 Phenylbutyrate
3 Selenite (Sodium)
3 VitK3,menadione
2 tamoxifen
2 Ajoene (compound of Garlic)
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 DTS(dibenzyl trisulphide) from Anamu
2 Andrographis
2 beta-glucans
2 Baicalin
2 Brucea javanica
2 brusatol
2 Bromelain
2 borneol
2 Genistein (soy isoflavone)
2 Butyrate
2 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
2 Thymol-Thymus vulgaris
2 Centella asiatica / Gotu kola → asiaticoside
2 Citric Acid
2 Carvone
2 Polyphenols
2 Cucurbitacin
2 Electrical Pulses
2 Chlorella (Chlorella vulgaris)
2 Flaxseed/Linseed
2 carboplatin
2 Hydrogen Gas
2 iodine
2 itraconazole
2 Lactobacillus
2 low dose naltrexone
2 Lemongrass Extract/Citral
2 SDG/lignans
2 Linalool
2 Lutein
2 Mangiferin
2 Methylglyoxal
2 Marjoram (Origanum majorana)
2 Propyl gallate
2 Phycocyanin
2 Rauwolfia serpentina/Indian Snakeroot
2 salinomycin
2 Selenium
2 Taurine
2 Vitamin K2
1 Coenzyme Q10
1 Acoschimperoside P, 2’-acetate
1 SonoDynamic Therapy UltraSound
1 Camptothecin
1 alpha Linolenic acid
1 Anethole/trans-Anethole
1 Angelica archangelica / Garden Angelica
1 Aspirin
1 Ascorbyl Palmitate
1 Trastuzumab
1 Atorvastatin
1 epirubicin
1 Isothiocyanates
1 selenomethionine
1 Black turtle bean
1 Zinc
1 Celastrol
1 Prebiotic
1 Cichoric acid / Chicoric acid
1 methotrexate
1 Hydroxycinnamic-acid
1 Citicoline, CDP-Choline
1 Copper and Cu NanoParticles
1 Oxaliplatin
1 CUSP9
1 Dichloroacetophenone(2,2-)
1 Dichloroacetate
1 Deguelin
1 Date Fruit Extract
1 Diindolylmethane
1 Fenbendazole
1 olaparib/LYNPARZA
1 Galloflavin
1 Ginkgo biloba
1 γ-linolenic acid (Borage Oil)
1 Gold NanoParticles
1 Grapeseed extract
1 hydrogen sulfide
1 HydroxyCitric Acid
1 Helleborus niger extracts – Christmas Rose
1 Hyperthermia
1 Huperzine A/Huperzia serrata
1 Rutin
1 Butein
1 Scopoletin
1 Vitamin C (Ascorbic Acid)
1 tumor necrosis factor-related apoptosis-inducing ligand
1 Lactoferrin/Talactoferrin
1 Methylene blue
1 mebendazole
1 MCT, metronomic chemo
1 methylseleninic acid
1 Magnetic Field Rotating
1 Moringin
1 Zeolite
1 Methylsulfonylmethane
1 Mushroom Chaga, Inonotus obliquus
1 Mushroom Shiitake, AHCC
1 Naringin
1 Neem
1 Oleocanthal
1 Orlistat
1 sericin
1 Physalin F & B
1 Piperine
1 Plumbagin
1 Psoralidin
1 Parthenolide
1 Pterostilbene
1 isoflavones
1 Sanguinarine
1 α-Santalol/Sandalwood oil
1 Scoulerine
1 polyethylene glycol
1 Selenium NanoParticles
1 Sesamin
1 Auranofin
1 Salvia miltiorrhiza
1 Spirulina(Arthrospira/Limnospira)
1 Spermidine
1 Terpinen-4-ol / Tea Tree Oil
1 Terpenoids
1 Aflavin-3,3′-digallate
1 Tomatine
1 Vitamin D3
1 Zerumbone
1 Zyflamend
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:27  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page